Affichage 51 à 52 des 52 essais cliniques
1 | 2 | 3 | 4 | 5 | 6 |
1 |
2 |
3 |
4 |
5 |
6 |
1 | 2 | 3 | 4 | 5 | 6 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 Versus Investigator's Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge
rechARge NCT06764485  Actif en recrutement
|
CISSS DU BAS-SAINT-LAURENT HOPITAL REGIONAL DE RIMOUSKI |
Isabelle Gagnon 418-724-3000 poste 8029 |
|
|
(EN) Pelvic Nodes Ultra-Hypo Fractionated Versus Conventionally Fractionated IMRT With HDR Brachytherapy Boost in Prostate Cancer: A Collaborative Multi-institutional Non-inferiority Phase 3 Trial.
PCS-XI NCT05820633 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
Lys Fernet 514-252-3400 poste 3227 |
Groupe d'étude en oncologie du Québec